Revised SPC: Adcetris (brentuximab vedotin) 50 mg powder for concentrate for solution for infusion

SPC has been updated with new indication of use in combination with cyclophosphamide, doxorubicin and prednisone for adult patients with previously untreated systemic anaplastic large cell lymphoma.

electronic Medicines compendium